Jesús Seco

481 total citations
10 papers, 378 citations indexed

About

Jesús Seco is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jesús Seco has authored 10 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Jesús Seco's work include Chemical Synthesis and Analysis (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Jesús Seco is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Jesús Seco collaborates with scholars based in Spain, United Kingdom and Netherlands. Jesús Seco's co-authors include Xavier Barril, F. Javier Luque, Jesús García, Ernest Giralt, Meritxell Teixidò, Teresa Tarragó, Salvador Guardiola, Laura Nevola, Sonia Ciudad and Pol Arranz‐Gibert and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Jesús Seco

10 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesús Seco Spain	8	277	119	63	56	45	10	378
Saliha Ece Acuner Türkiye	8	336 1.2×	85 0.7×	51 0.8×	26 0.5×	55 1.2×	10	456
E. Allen Sickmier United States	11	458 1.7×	48 0.4×	54 0.9×	43 0.8×	43 1.0×	18	618
James R. Valcourt United States	4	456 1.6×	82 0.7×	33 0.5×	52 0.9×	35 0.8×	6	537
Steven Shave United Kingdom	12	201 0.7×	75 0.6×	66 1.0×	27 0.5×	31 0.7×	25	326
Evert Homan Sweden	14	332 1.2×	55 0.5×	52 0.8×	16 0.3×	27 0.6×	27	485
Tao Xie United States	7	275 1.0×	28 0.2×	62 1.0×	20 0.4×	77 1.7×	18	452
Yukang Gong China	12	336 1.2×	68 0.6×	49 0.8×	16 0.3×	62 1.4×	12	540
François Degorce France	5	275 1.0×	30 0.3×	84 1.3×	46 0.8×	36 0.8×	9	458
Samia Aci‐Sèche France	12	241 0.9×	88 0.7×	48 0.8×	21 0.4×	39 0.9×	27	361
Lalima G. Ahuja United States	13	562 2.0×	122 1.0×	48 0.8×	18 0.3×	109 2.4×	17	656

Countries citing papers authored by Jesús Seco

Since Specialization

Citations

This map shows the geographic impact of Jesús Seco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Seco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Seco more than expected).

Fields of papers citing papers by Jesús Seco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Seco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Seco. The network helps show where Jesús Seco may publish in the future.

Co-authorship network of co-authors of Jesús Seco

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Seco. A scholar is included among the top collaborators of Jesús Seco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Seco. Jesús Seco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Pallara, Chiara, Sònia Brun, Jesús Seco, et al.. (2022). Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds. Scientific Reports. 12(1). 15810–15810. 5 indexed citations

Ayerbe-Algaba, Rafael, Núria Bayó‐Puxán, Jesús Seco, et al.. (2021). AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections. Frontiers in Microbiology. 12. 634323–634323. 7 indexed citations

Broekaart, Diede W. M., A. Korotkov, Oleg Senkov, et al.. (2020). The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects. Journal of Clinical Investigation. 131(1). 37 indexed citations

Konopka, Anna, Emilia Rejmak, Ewa Bulska, et al.. (2019). Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors. Bioorganic Chemistry. 94. 103365–103365. 17 indexed citations

Arranz‐Gibert, Pol, Sonia Ciudad, Jesús Seco, et al.. (2018). Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides. Scientific Reports. 8(1). 6446–6446. 29 indexed citations

Guardiola, Salvador, Jesús Seco, Mónica Varese, et al.. (2017). Toward a Novel Drug To Target the EGF–EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides. ChemBioChem. 19(1). 76–84. 24 indexed citations

Guardiola, Salvador, et al.. (2015). Peptides Targeting EGF Block the EGF–EGFR Interaction. ChemBioChem. 17(8). 702–711. 22 indexed citations

Baranger, Kévin, Santiago Rivera, Fabian D. Liechti, et al.. (2014). Endogenous and synthetic MMP inhibitors in CNS physiopathology. Progress in brain research. 214. 313–351. 38 indexed citations

Seco, Jesús, et al.. (2011). Allosteric regulation of PKCθ: Understanding multistep phosphorylation and priming by ligands in AGC kinases. Proteins Structure Function and Bioinformatics. 80(1). 269–280. 11 indexed citations

10.

Seco, Jesús, F. Javier Luque, & Xavier Barril. (2009). Binding Site Detection and Druggability Index from First Principles. Journal of Medicinal Chemistry. 52(8). 2363–2371. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact